# Benzonatate

NDC: 0615-8403
Generic name: Benzonatate
Labeler / Manufacturer: NCS HealthCare of KY, LLC dba Vangard Labs
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20161210

FDA application: ANDA091133

## Active ingredients

- BENZONATATE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0615-8403"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0615-8403
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f5c19ad-d811-4196-a9c3-4f6b89626b83